Trisubstituted 1,2,4-triazoles

Details for Australian Patent Application No. 2007239498 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Dinklo, Theodorus; Lesage, Anne Simone Josephine; De Bruyn, Marcel Frans Leopold; Van Roosbroeck, Yves Emiel Maria; MacDonald, Gregor James; Zhuang, Wei; Duffy, James Edward Stewart; Van Den Keybus, Frans Alfons Maria; Thuring, Johannes Wilhelmus John F.

Agent Shelston IP

Pub. Number AU-B-2007239498

PCT Pub. Number WO2007/118903

Priority 06112754.4 19.04.06 EP

Filing date 19 April 2007

Wipo publication date 25 October 2007

Acceptance publication date 23 August 2012

International Classifications

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

A61K 31/4196 - 1,2,4-Triazoles

A61P 25/00 Drugs for disorders of the nervous system

C07D 249/08 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 405/04 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

27 November 2008 PCT application entered the National Phase

  PCT publication WO2007/118903 Priority application(s): WO2007/118903

23 August 2012 Application Accepted

  Published as AU-B-2007239498

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007239505-Novel crystalline compounds

2007239494-Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor